Back to Journals » Cancer Management and Research
Cancer Management and Research
Editor-in-Chief: Professor Yong Teng
Cancer Management and Research is part of our Elevate Series. This means that you will receive a concierge-level publishing experience, including dedicated support from our expert in-house Editorial team.
An international, peer reviewed, open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
This journal offers Accelerated Publication.
Articles:
- View all (5203)
- Volume 18, 2026 (169)
- Volume 17, 2025 (276)
- Volume 16, 2024 (164)
- Volume 15, 2023 (153)
- Volume 14, 2022 (330)
- Volume 13, 2021 (890)
- Volume 12, 2020 (1256)
- Volume 11, 2019 (969)
- Volume 10, 2018 (645)
- Volume 9, 2017 (89)
- Volume 8, 2016 (17)
- Volume 7, 2015 (33)
- Volume 6, 2014 (43)
- Volume 5, 2013 (41)
- Volume 4, 2012 (47)
- Volume 3, 2011 (32)
- Volume 2, 2010 (32)
- Volume 1, 2009 (17)
Latest articles:
- 5 records -
Multidisciplinary Palliative Care and Its Impact on Symptom Burden and Quality of Life in Advanced Cancer Patients in Ethiopia: A Pre–Post Quasi-Experimental Study
Fentie AM, Seife E, Ozawa S, Fenta TG
Cancer Management and Research 2026, 18:624631
Published Date: 17 July 2026
Prognostic Factors in Upper Gastrointestinal Neuroendocrine Carcinoma: A Retrospective Cohort Study of Clinicopathological Features and Survival Outcomes
Şeyran E, Gökmen A
Cancer Management and Research 2026, 18:618644
Published Date: 17 July 2026
Development and Validation of a Clinical Radiomics Nomogram for Predicting Early Recurrence After Microwave Ablation in Hepatocellular Carcinoma Patients With Type 2 Diabetes
Sun Z, Wang N, Wu X, Wang T, Liu D, Zou Y, He R, Jia N
Cancer Management and Research 2026, 18:617875
Published Date: 17 July 2026
Anticancer Activity and Cell Mechanism of a Novel Flavonoid Derivative from Chrysanthemum × morifolium (Ramat). Hemsl Leaves Against the MCF-7 Breast Cancer Line in vitro
Maesaroh I, Muhaimin M, Abdulah R, Barliana MI
Cancer Management and Research 2026, 18:618125
Published Date: 16 July 2026
Clonal Seborrheic Keratosis with Adjacent Bowen’s Disease in a Non-Sun-Exposed Patient: Collision or Transformation?
Wang Z, Mao S, Xiao H, Zhao Q
Cancer Management and Research 2026, 18:602855
Published Date: 15 July 2026